-transparent.png){kind=logo}
Benign prostatic hypertrophy is the cause of urinary outflow obstruction in the majority of men older than 50 years. Even if the pathophysiology of BPH is multifactorial, its development needs testicular androgens and aging. Androgen deprivation is the only approach that may reduce the hyperplastic state. This article reviews the endocrine aspect of BPH and the various hormonal treatment strategies, concerning clinical efficacy and side effects.
Related Publications
R Tenaglia, and
M Nicolai, and
G Di Federico, and
R Iantorno, and
A Zezza, and
G Lombardi
January 1975,
Vitamins and hormones,
R Tenaglia, and
M Nicolai, and
G Di Federico, and
R Iantorno, and
A Zezza, and
G Lombardi
October 1975,
The Journal of clinical endocrinology and metabolism,
R Tenaglia, and
M Nicolai, and
G Di Federico, and
R Iantorno, and
A Zezza, and
G Lombardi
January 2005,
Archives of andrology,
R Tenaglia, and
M Nicolai, and
G Di Federico, and
R Iantorno, and
A Zezza, and
G Lombardi
January 1989,
Journal of receptor research,
R Tenaglia, and
M Nicolai, and
G Di Federico, and
R Iantorno, and
A Zezza, and
G Lombardi
March 1983,
Hinyokika kiyo. Acta urologica Japonica,
R Tenaglia, and
M Nicolai, and
G Di Federico, and
R Iantorno, and
A Zezza, and
G Lombardi
August 1993,
The Practitioner,
R Tenaglia, and
M Nicolai, and
G Di Federico, and
R Iantorno, and
A Zezza, and
G Lombardi
June 1994,
Iowa medicine : journal of the Iowa Medical Society,
R Tenaglia, and
M Nicolai, and
G Di Federico, and
R Iantorno, and
A Zezza, and
G Lombardi
January 1993,
European urology,
R Tenaglia, and
M Nicolai, and
G Di Federico, and
R Iantorno, and
A Zezza, and
G Lombardi
April 1957,
Journal of gerontology,
R Tenaglia, and
M Nicolai, and
G Di Federico, and
R Iantorno, and
A Zezza, and
G Lombardi
July 1991,
American family physician,
